>
CarnabioCarnabio
Carnabio公司是一家日本的生物科技公司,致力于藥物開發(fā)研制,經(jīng)營(yíng)生物制劑等的銷售。Carnabio不斷的研究和開發(fā)新的藥物,這些藥物主要用于治療癌癥和炎癥性疾病。該公司使用了創(chuàng)新激酶藥物發(fā)現(xiàn)平臺(tái)QuickScout?。
Drug Discovery Support Business provide drug discovery supporting products and services. Identify and develop new medicines primarily for the treatment of cancer and inflammatory diseases using own innovative kinase drug discovery platform, QuickScout?
產(chǎn)品列表:
序號(hào) |
品牌 |
名稱 |
貨號(hào) |
規(guī)格 |
1 |
Carnabio |
AKT1 |
01-101 |
5ug/10ug |
2 |
Carnabio |
ALK[G1202R] |
08-544 |
5ug/10ug |
3 |
Carnabio |
AMPKα1/β1/γ1 |
02-113 |
5ug/10ug |
4 |
Carnabio |
BRSK2 |
02-116 |
5ug/10ug |
5 |
Carnabio |
CaMK4 |
02-108 |
5ug/10ug |
6 |
Carnabio |
CDK4/CycD3 |
04-105 |
5ug/10ug |
7 |
Carnabio |
CDK5/P25 |
04-106 |
5ug/10ug |
8 |
Carnabio |
CDK9 |
04-110 |
5ug/10ug |
9 |
Carnabio |
CHK2 |
02-162 |
5ug/10ug |
10 |
Carnabio |
DCAMKL1 |
02-139 |
5ug/10ug |
11 |
Carnabio |
DCAMKL2 |
02-140 |
5ug/10ug |
12 |
Carnabio |
DDR2 |
08-114 |
5ug/10ug |
13 |
Carnabio |
EGFR |
08-115 |
5ug/10ug |
14 |
Carnabio |
EGFR(d746-750/T790M) |
08-528 |
5ug/10ug |
15 |
Carnabio |
EGFR[L861Q] |
08-513 |
5ug/10ug |